Desitin Arzneimittel GmbH is a European pharmaceutical company specializing in the development, production, and distribution of medicines, primarily for neurological and psychiatric diseases. The company focuses on treatments for epilepsy and Parkinson's disease, offering a wide range of products, including nearly all anticonvulsants deemed essential by the WHO. Based in Hamburg, Germany, Desitin operates internationally with a presence in various European countries.